Jewish American Heritage Month

Posted By admin on January 18, 2021

Israeli hospital: 98% of staff who got 2nd shot have high-level COVID antibodies

A new serological study conducted at Sheba Medical Center in Ramat Gan has shown 98% of hospital workers who received the second dose of the coronavirus vaccine have developed a high level of antibodies to fight off the virus.

The study of 102 samples, taken a week after Israel began administering the second dose when the vaccine is expected to reach peak effectiveness showed most vaccinees had higher antibody counts than among those who have recovered from COVID-19.

The hospital says that a week after receiving the final dose, antibodies jumped to a level between 6 and 20 times higher than that observed after the first shot.

Hundreds more samples are set to be examined.

Two employees developed only low levels of antibodies, the tests showed one of them known to have a weakened immune system.

Dr. Gili Regev-Yochay, director of the Infectious Disease Epidemiology Unit at Sheba, says that the initial results indicate the vaccinees are unlikely to be carriers or infectious a matter that scientists have hitherto not determined as antibody levels are high enough to suppress any virus particles.

Sheba Medical staff members receive the second round of the Covid-19 vaccine, at the Sheba Medical Center outside of Tel Aviv, on January 10, 2021 (Miriam Alster/Flash90)

This means the vaccine works wonderfully, Regev-Yochay says. The results are in agreement with Pfizers trials and go even beyond the expected [results]. I expect the tests of the rest of the employees participating to be similar.

She adds: There is definitely cause for optimism.

See the original post here:
Report: New bleak forecast says Israel could see large new COVID wave in March - The Times of Israel

Category: Zionism
Tags: